Opinion: Is public a guinea pig for claims of CBD’s effectiveness?
WASHINGTON — As a new-product junkie, it was foregone that I’d swap a C-note for something called CBD, a cannabis extract promising relief from pain and anxiety, the twin banes of baby boomers recently awakened to the realization that, though their spirits be forever young, their joints definitively are... Read more
Cannabis vaping startup Pax valued at $5 billion
Passing a joint is becoming increasingly passe. Pax Labs Inc., a San Francisco-based startup that makes marijuana vaporizers, is now valued at $5 billion, said two people familiar with the company who asked not to be identified discussing the terms of a private deal. The company raised $20 million... Read more
Marijuana is emerging among California’s vineyards, offering promise and concern
SANTA YNEZ VALLEY, Calif. — It is the fall harvest here in this fertile stretch of oaks and hills that produces some of the country’s best wine. This season, though, workers also are plucking the sticky, fragrant flowers of a new crop. Marijuana is emerging among the vineyards, not... Read more
North Coast cannabis marketplace sees surge among health and wellness users
The legalization of cannabis for recreational use this year has brought new consumers into the fold of the multibillion-dollar retail marketplace in California — but not all are looking to get high. In fact, the easing of the stigma over cannabis has caused a surge this year of people... Read more
Cannabis dispensary giant MedMen boosts U.S. footprint with major deal
MedMen Enterprises Inc., one of the most prominent companies in the expanding cannabis industry, agreed to buy medical pot firm PharmaCann for $682 million, boosting its presence across the U.S. The all-stock purchase, which will give MedMen 10 additional dispensaries and licenses for several more, is one of the... Read more
Opinion: Big Tobacco finally wakes up and smells the cannabis
Big Tobacco is finally ready to say, pass that dutch. Altria Group Inc., the biggest U.S. cigarette company, is reportedly in talks to buy a stake in Aphria Inc., one of a growing number of Canadian cannabis producers that’s attracted the attention of investors this year. The discussions were... Read more
San Diego company testing marijuana-derived multiple sclerosis therapy
Emerald Health Pharmaceuticals of San Diego has begun using a marijuana-derived therapy to experimentally treat small numbers of people who suffer from multiple sclerosis and scleroderma, a pair of autoimmune diseases. The small, phase 1 safety trial involves CBD, a compound found in marijuana. CBD has caught the attention... Read more
As cannabis market heats up, scientists race to build ‘weed biofactories’
dSAN DIEGO — Scientists are hustling on behalf of the weed industry to find new ways to produce the most valuable compounds in marijuana, ditching greenhouses in favor of big steel vats of yeast that can ‘brew’ cannabis like Budweiser brews beer. The science, once brought to market, would... Read more
Pico Rivera extends recreational marijuana ban again in wake of City Hall departures
Stymied by a short-staffed City Hall, the Pico Rivera City Council for a third time is “kicking the can” on tackling recreational marijuana and voted to extend a temporary ban on dispensaries. The cultivation and sale of recreational marijuana will continue to be banned in Pico Rivera for another... Read more
With Canada poised to cash in on cannabis, U.S. executives eager for their turn
Mainstream executives want in on the cannabis craze. That’s not surprising, with the value of some Canadian pot businesses topping $10 billion and Coca-Cola Co. and Molson Coors Brewing Co. eyeing marijuana as the next trendy ingredient. But the burgeoning industry faces a unique hurdle: Pot is still illegal... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )